我院2012-2013年麻醉性镇痛药应用分析

发布时间：2018-05-25 18:29

本文选题：癌痛 + 麻醉药品　；参考：《中国药房》2015年11期

【摘要】：目的:为麻醉药品的规范化管理和临床合理用药提供参考。方法:采用回顾性分析方法,调取我院2012-2013年麻醉性镇痛药处方信息,对总用量、销售金额、用药频度(DDDs)、日均费用(DDC)等进行统计分析。结果:2013年我院麻醉性镇痛药销售金额较2012年增长22%,以盐酸羟考酮缓释片(40 mg)增幅最大(42%);2012年及2013年DDDs值排名前3的药物均分别为盐酸羟考酮缓释片(40 mg)、盐酸羟考酮缓释片(10 mg)及芬太尼透皮贴剂(8.4 mg);2012年及2013年DDC值排名前3的药物均分别为盐酸哌替啶注射液、芬太尼透皮贴剂(4.2 mg)、盐酸羟考酮缓释片(10 mg)。结论:我院麻醉性镇痛药品种齐全,癌痛治疗总体符合世界卫生组织《癌痛三阶梯治疗原则》,但仍存在一些问题,需要进一步改进。
[Abstract]:Objective: to provide reference for standardized management of narcotic drugs and rational use of drugs in clinic. Methods: the prescription information of anesthetic analgesics in our hospital from 2012 to 2013 was collected by retrospective analysis. The total dosage, sales amount, DDDsC, daily average cost and DDCwere statistically analyzed. Results: the sales amount of anesthetic analgesics in our hospital in 2013 was 22% higher than that in 2012, and the biggest increase was 40 mg / kg hydroxycodone hydrochloride sustained release tablets and 40 mg / kg hydroxycodone hydrochloride sustained-release tablets in 2012 and 2013 respectively. Sustained-release tablets (10 mg) and fentanyl transdermal patch (8. 4 mg / L), and pethidine hydrochloride injection were the top 3 drugs in 2012 and 2013, respectively. Fentanyl transdermal patch was 4. 2 mg / L, hydroxycodone hydrochloride sustained release tablet was 10 mg / g. Conclusion: the variety of anaesthetic analgesics in our hospital is complete, and the treatment of cancer pain accords with the World Health Organization (WHO), but there are still some problems, which need to be further improved.
【作者单位】：中国医学科学院肿瘤医院药剂科;
【分类号】：R95

【参考文献】